2021;41:BSR20210611
Product Name: Ipamorelin Strength:10mg Chemical Name: Growth Hormone Secretagogue Peptide (Selective Ghrelin Receptor Agonist) CAS Number: 170851-70-4 Molecular Formula: CHNO Molecular Weight: 711.85 g/mol Amino Acid Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH Appearance: White to Off-White Lyophilized Powder Classification: Peptide Hormone Analogue Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Growth Hormone Recovery & Performance Store lyophilized material refrigerated at 28C for routine storage
BUY 2, SAVE 5% 34.95 33.20 / ITEM BUY 3, SAVE 10% 34.95 31.46 / ITEM Highest Value BUY 4, SAVE 15% 34.95 29.71 / ITEM Table of Contents Product Summary What is CJC-1295 (no DAC) & Ipamorelin Blend 10mg
Business Type Distributor, Supplier, Wholesaler, Retailer Related Products Explore Related Categories More Products From This Seller Seller Details GST - 08AACCM6348N2ZX Accepts only Foreign inquiries MN HOSPITAL RESEARCH CENTRE CAMPUS, OPPOSITE KARNI SINGH STADIUM ROAD, Bikaner, Rajasthan, 334001, India pharmaceutical injection in Bikaner Recommended Products Compare With Similar Products Price Or Price Range 18000 INR (Approx.) 19000 INR (Approx.) Drug Type Other Types General Medicines Suitable For Suitable For All Suitable For All Payment Terms Cash Advance (CA), Cash on Delivery (COD), Western Union, Cash Against Delivery (CAD), Others, Cash in Advance (CID) Cash on Delivery (COD), Others, Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Cash Advance (CA) Sample Policy Contact us for information regarding our sample policy Contact us for information regarding our sample policy Main Export Market(s) Australia, North America, South America, Eastern Europe, Middle East, Africa, Western Europe, Central America, Asia Eastern Europe, Africa, Australia, Middle East, South America, Western Europe, Asia, Central America, North America People Also Viewed
Can glutathione be combined with other treatments
In summary, the risk of clinically significant liver injury at therapeutic doses of paracetamol is very low
